Janus Henderson Group PLC Protara Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
A detailed history of Janus Henderson Group PLC transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,271,832 shares of TARA stock, worth $9.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,271,832Holding current value
$9.66 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TARA
# of Institutions
60Shares Held
23.4MCall Options Held
58.3KPut Options Held
110K-
Ra Capital Management, L.P. Boston, MA3.4MShares$14.5 Million0.29% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.25MShares$9.56 Million0.02% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A62.09MShares$8.88 Million0.02% of portfolio
-
Opaleye Management Inc. Boston, MA1.83MShares$7.76 Million1.88% of portfolio
-
Blackstone Inc New York, NY1.68MShares$7.14 Million0.04% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $47.9M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...